Chronic Lymphocytic Leukemia (CLL) Model for Time to First Treatment

Purpose: To predict the time to first treatment for a patient with CLL using the model of Wierda et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient newly diagnosed with CLL?

Yes

Number of lymph node sites involved

Diameter of the largest lymph node in the neck

Is IGHV mutated?

Yes

Serum LDH

FISH findings

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total score

Median treatment-free survival

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Prognostic Score of Tsimberidou et al for a Patient with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (University of Texas M.D. Anderson Cancer Center Score)
Severity, Prognosis, Stage
- Rai Staging System for Chronic Lymphocytic Leukemia (CLL)
- Prognostic Score of Tsimberidou et al for a Patient with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (University of Texas M.D. Anderson Cancer Center Score)
Complications
- Prognostic Score of Tsimberidou et al for a Patient with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (University of Texas M.D. Anderson Cancer Center Score)

Therapy

Selection
- Prognostic Score of Tsimberidou et al for a Patient with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (University of Texas M.D. Anderson Cancer Center Score)

Monitoring

Response To Therapy
- Criteria of National Cancer Institute (NCI) for Response to Therapy in B-Cell CLL

Specialty

Hematology Oncology

Objective

selection

ICD-10

C91.1 - Chronic lymphocytic leukaemia of B-cell type

Info

Purpose: To predict the time to first treatment for a patient with CLL using the model of Wierda et al.

Specialty: Hematology Oncology

Objective: selection

ICD-10: C91.1,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path